Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company’s NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologo... Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company’s NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of Alzheimer’s disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.02276 | -2.86808810928 | 0.79356 | 0.85 | 0.72 | 16975 | 0.78924104 | CS |
| 4 | 0.075875 | 10.9184444364 | 0.694925 | 0.85 | 0.600146 | 13673 | 0.73986675 | CS |
| 12 | -0.0568 | -6.86321894635 | 0.8276 | 0.9699 | 0.600146 | 11221 | 0.77992706 | CS |
| 26 | 0.2108 | 37.6428571429 | 0.56 | 0.9699 | 0.4589 | 18381 | 0.67531962 | CS |
| 52 | 0.0708 | 10.1142857143 | 0.7 | 0.9699 | 0.4589 | 31291 | 0.69145483 | CS |
| 156 | -3.4192 | -81.6038186158 | 4.19 | 4.19 | 0.4589 | 30485 | 0.69145483 | CS |
| 260 | -3.4192 | -81.6038186158 | 4.19 | 4.19 | 0.4589 | 29720 | 0.69145483 | CS |
Ranb2khz
6分前
Yachtmaster
15分前
knrorrel
21分前
knrorrel
28分前
PC retired
45分前
sharkey1
1時間前
sharkey1
2時間前
Libertas
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。